Organon & Co.
OGN · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $4 | $4 | $7 | $8 |
| - Cash | $1 | $1 | $1 | $1 |
| + Debt | $9 | $9 | $9 | $9 |
| Enterprise Value | $12 | $12 | $16 | $16 |
| Revenue | $6 | $6 | $6 | $6 |
| % Growth | 2.2% | 1.4% | -2.1% | – |
| Gross Profit | $4 | $4 | $4 | $4 |
| % Margin | 58% | 59.8% | 62.8% | 62.2% |
| EBITDA | $2 | $1 | $2 | $2 |
| % Margin | 25.1% | 22.9% | 28.4% | 31.4% |
| Net Income | $1 | $1 | $1 | $1 |
| % Margin | 13.5% | 16.3% | 14.9% | 21.4% |
| EPS Diluted | 3.33 | 3.99 | 3.59 | 5.33 |
| % Growth | -16.5% | 11.1% | -32.6% | – |
| Operating Cash Flow | $1 | $1 | $1 | $2 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $1 | $1 | $0 | $2 |